Survey of Ophthalmology
Volume 51, Issue 4 , Pages 419-433, July 2006

Conjunctival Amyloidosis: Report of Six Cases and Review of the Literature

  • Hakan Demirci, MD

      Affiliations

    • Oncology Service
  • ,
  • Carol L. Shields, MD

      Affiliations

    • Oncology Service
    • Corresponding Author InformationReprint address: Carol L. Shields, M.D., Oncology Service, Wills Eye Hospital, 840 Walnut Street, Philadelphia, PA 19107.
  • ,
  • Ralph C. Eagle Jr., MD

      Affiliations

    • Pathology Department, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA
  • ,
  • Jerry A. Shields, MD

      Affiliations

    • Oncology Service

STEFAN SEREGARD AND MILTON BONIUK, EDITORS

Abstract 

Conjunctival amyloidosis is an uncommon condition that occasionally is associated with systemic involvement. The clinical presentations of conjunctival amyloidosis are diverse. We present six patients with conjunctival amyloidosis who were referred to us with the suspicion of another conjunctival lesion. The conjunctival lesion was circumscribed in two patients and diffuse in four patients. The lesion color was yellow in one patient and yellow-pink in five patients. The associated features were intrinsic vascularization (six patients), recurrent subconjunctival hemorrhage (four patients) and blepharoptosis that involved the palpebral conjunctiva (two patients). Systemic evaluation revealed primary systemic amyloidosis in one patient and no related systemic abnormalities in five patients. Management consisted of complete excisional biopsy for the two circumscribed lesions and incisional biopsy for the four diffuse lesions. Two patients with diffuse involvement showed progressive involvement of the conjunctiva over 3 years following incisional biopsy and the other four patients remained stable. Additionally, there was no systemic involvement in five patients. In conclusion, conjunctival amyloidosis generally manifests as a yellowish-pink, hemorrhagic mass deep to the epithelium. Most patients show no evidence of systemic amyloidosis.

Key words: adnexa, amyloid, amyloidosis, conjunctiva, eye, lymphoma, subconjunctival hemorrhage, tumor

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article. Support was provided by the Paul Kayser International Award of Merit in Retina Research, Houston, TX (J. Shields), Macula Foundation, New York, NY (C. Shields), the Noel T. and Sara L. Simmonds Endowment for Ophthalmic Pathology, Wills Eye Hospital (R. Eagle, Jr.) and the Eye Tumor Research Foundation, Philadelphia, PA (C. Shields).

PII: S0039-6257(06)00080-4

doi:10.1016/j.survophthal.2006.04.007

Survey of Ophthalmology
Volume 51, Issue 4 , Pages 419-433, July 2006